Efsubaglutide Alfa 20 mg QW

DRUG2 trials

Sponsors

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Conditions

Adolescence ObesityObesity and Overweight

Phase 1

Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

RecruitingNCT07693426

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Adolescence Obesity

Start: 2026-07-16End: 2027-08-31Target: 36Updated: 2026-07-30

Phase 2

The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）

RecruitingNCT07114419

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Obesity and Overweight

Start: 2025-08-25End: 2026-08-01Target: 200Updated: 2025-12-02